Insider · CIK 0001351073

ValueAct Capital Management, LLC

CIK 0001351073 Name as filed on the most recent filing

Filed as ValueAct Capital Management, LLC (365)

991 transaction lines · from 365 filings · filed 2006-02-15 to 2025-12-08 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised. The 40 most recent are shown; the catalog may hold more for this insider.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2006-10-03 P, Open-market purchase Hanover Compressor Co /HC 5,181,000, acquired Open Form 4 filing 0001129787-06-000181
2006-10-02 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 1,966,000, acquired Open Form 4 filing 0001129787-06-000179
2006-09-29 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 811,456, acquired Open Form 4 filing 0001129787-06-000172
2006-09-28 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 1,170,771, acquired Open Form 4 filing 0001129787-06-000172
2006-09-27 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 354,600, acquired Open Form 4 filing 0001129787-06-000172
2006-09-22 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 2 lines 1,963,500, acquired Open Form 4 filing 0001129787-06-000169
2006-09-21 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 2 lines 2,998,000, acquired Open Form 4 filing 0001129787-06-000169
2006-09-19 P, Open-market purchase Gevity HR IncGVHR 651,550, acquired Open Form 4 filing 0001129787-06-000168
2006-09-19 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 2,109,132, acquired Open Form 4 filing 0001129787-06-000167
2006-09-18 P, Open-market purchase Gevity HR IncGVHR 5,569,605, acquired Open Form 4 filing 0001129787-06-000168
2006-09-15 P, Open-market purchase Gartner IncIT 31,500,000, acquired Open Form 4 filing 0001129787-06-000166
2006-09-15 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 2 lines 2,001,750, acquired Open Form 4 filing 0001129787-06-000167
2006-09-14 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 2,200,000, acquired Open Form 4 filing 0001129787-06-000160
2006-09-13 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 366,000, acquired Open Form 4 filing 0001129787-06-000160
2006-09-12 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 2 lines 2,093,950, acquired Open Form 4 filing 0001129787-06-000160
2006-09-11 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 2 lines 2,107,962, acquired Open Form 4 filing 0001129787-06-000159
2006-09-08 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 585,000, acquired Open Form 4 filing 0001129787-06-000159
2006-09-07 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 157,950, acquired Open Form 4 filing 0001129787-06-000159
2006-08-29 P, Open-market purchase PER SE Technologies IncPSTI 65,970, acquired Open Form 4 filing 0001129787-06-000154
2006-08-29 S, Open-market sale Mentor Corp /MN/MNT 13,909,150, disposed Open Form 4 filing 0001129787-06-000153
2006-08-28 S, Open-market sale Mentor Corp /MN/MNT 11,595,933, disposed Open Form 4 filing 0001129787-06-000153
2006-08-25 P, Open-market purchase PER SE Technologies IncPSTI 1,437,316, acquired Open Form 4 filing 0001129787-06-000149
2006-08-24 P, Open-market purchase PER SE Technologies IncPSTI 3,507,200, acquired Open Form 4 filing 0001129787-06-000149
2006-08-23 P, Open-market purchase PER SE Technologies IncPSTI 448,540, acquired Open Form 4 filing 0001129787-06-000149
2006-08-21 P, Open-market purchase PER SE Technologies IncPSTI 2 lines 4,073,886, acquired Open Form 4 filing 0001129787-06-000145
2006-08-18 P, Open-market purchase PER SE Technologies IncPSTI 20,614, acquired Open Form 4 filing 0001129787-06-000145
2006-08-17 P, Open-market purchase PER SE Technologies IncPSTI 2 lines 2,455,270, acquired Open Form 4 filing 0001129787-06-000145
2006-08-11 S, Open-market sale Mentor Corp /MN/MNT 30,242,036, disposed Open Form 4 filing 0001129787-06-000141
2006-08-10 S, Open-market sale Mentor Corp /MN/MNT 38,270,892, disposed Open Form 4 filing 0001129787-06-000141
2006-08-08 P, Open-market purchase Gevity HR IncGVHR 45,960, acquired Open Form 4 filing 0001129787-06-000135
2006-08-07 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 1,448,195, acquired Open Form 4 filing 0001129787-06-000134
2006-08-07 P, Open-market purchase Gevity HR IncGVHR 573,750, acquired Open Form 4 filing 0001129787-06-000135
2006-08-03 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 6,483,600, acquired Open Form 4 filing 0001129787-06-000134
2006-08-03 P, Open-market purchase Gevity HR IncGVHR 262,688, acquired Open Form 4 filing 0001129787-06-000133
2006-08-02 P, Open-market purchase Gevity HR IncGVHR 2 lines 3,766,918, acquired Open Form 4 filing 0001129787-06-000133
2006-08-01 P, Open-market purchase Gevity HR IncGVHR 2 lines 2,132,500, acquired Open Form 4 filing 0001129787-06-000133
2006-07-28 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 1,700, acquired Open Form 4 filing 0001129787-06-000120
2006-07-27 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 1,698,000, acquired Open Form 4 filing 0001129787-06-000120
2006-07-27 P, Open-market purchase PRA InternationalPRAI 343,830, acquired Open Form 4 filing 0001129787-06-000119
2006-07-26 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 545,790, acquired Open Form 4 filing 0001129787-06-000120
2006-07-26 P, Open-market purchase PRA InternationalPRAI 448,980, acquired Open Form 4 filing 0001129787-06-000119

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. ValueAct Capital Management, LLC, insider transactions. Retrieved 2026-08-28 from https://ebomi.com/insider/0001351073

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.